Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: Experience from the Latin American screening study

International Journal of Gynecological Cancer

Volumn 16, Issue 3, 2006, Pages 955-962

  Longatto Filho, A ^a,b   Erzen M ^c   Branca, M ^d   Roteli Martins, C ^e   Naud, P ^f   Derchain, S F M ^g   Hammes, L ^f   Sarian, L O ^g   Braganca J F ^g   Matos, J ^f   Gontijo, R ^g   Lima, T ^e   Maeda, M Y S ^a,b   Tatti, S ^f   Syrjanen S ^g   Dores, G ^h   Lorincz A ⁱ   Syrjanen K ^g  

^a INSTITUTO ADOLFO LUTZ   (Brazil)

^b UNIVERSITY OF MINHO   (Portugal)

^c SIZE Diagnostic Center   (Slovenia)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e HOSPITAL MATERNIDADE LEONOR MENDES DE BARROS   (Brazil)

^f HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^g UNIVERSITY OF CAMPINAS   (Brazil)

^h Digene Brasil   (Brazil)

ⁱ Digene Corporation   (United States)

Author keywords

Cervical cancer; HPV testing; Low resource setting; Screening

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; COHORT ANALYSIS; CONFIDENCE INTERVAL; CYTOLOGY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUALITY; SMOKING; SOUTH AND CENTRAL AMERICA; TIME SERIES ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; VIRUS STRAIN; WART VIRUS;

ADULT; ALGORITHMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH RESOURCES; HUMANS; LATIN AMERICA; MASS SCREENING; MIDDLE AGED; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRIDAE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; SEXUAL BEHAVIOR; SEXUAL PARTNERS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33745104064     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00582.x     Document Type: Article

References (27)

1. Bergström R Sparen P Adami HO. Trends in cancer of the cervix uteri in Sweden following cytological screening. Br J Cancer 1999 81 : 159 66.
2. Vizcaino AP Moreno V Bosch FX et al. International trends in incidence of cervical cancer: II. Squamous-cell carcinoma. Int J Cancer 2000 86 : 429 35.
3. Nanda K McGregory DC Myers ER et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 2000 132 : 810 9.
4. Wright TC Jr. Cox JT Massad LS Twiggs LB Wilkinson EJ ASCCP-Sponsored Consensus Conference. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002 287 : 2120 9.
5. Schiffman M Solomon D. Findings to date from the ASCUS-LSIL Triage Study (ALTS). Arch Pathol Lab Med 2003 127 : 946 9.
6. Apgar BS Zoschnick L Wright TC Jr. The 2001 Bethesda System terminology. Am Fam Physician 2003 68 : 1992 8.
7. International Agency for Research on Cancer (IARC) Working group. Human papillomaviruses. Vol. 64. Lyon, France : World Health Organization, IARC, 1995.
8. Walboomers JM Jacobs MV Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999 189 : 12 9.
9. Kulasingam SL Hughes JP Kiviat NB et al. Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral. JAMA 2002 288 : 1749 57.
10. Sherman ME Lorincz AT Scott DR et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst 2003 95 : 46 52.
11. Petry KU Menton S Menton M et al. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer 2003 88 : 1570 7.
12. Lorincz AT Richart RM. Human papillomavirus DNA testing as an adjunct to cytology in cervical screening programs. Arch Pathol Lab Med 2003 127 : 959 68.
13. Kim JJ Wright TC Goldie SJ. Cost-effectiveness of human papillomavirus DNA testing in the United Kingdom, The Netherlands, France, and Italy. J Natl Cancer Inst 2005 97 : 888 95.
14. Wright TC Jr. Schiffman M Solomon D et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 2004 103 : 304 9.
15. Ministério da Saúde - Instituto Nacional do Câncer. Atlas de Mortalidade por Câncer no Brasil 1979-1999. Rio de Janeiro. INCA, 2002. Available at : http://www.inca.gov.br/atlas/docs/Atlas_completo.pdf only Portuguese ME van Ballegooijen M van Oortmarssen GJ Boer R Habbema JD. Cost-effectiveness of cervical cancer screening: comparison of screening policies. J Natl Cancer Inst 2002 94 : 193 204.
16. International Agency for Research on Cancer. Cancer incidence in five continents. Vol. 5. Lyon, France : IARC Press, 2002.
17. Syrjänen K Naud P Derchain SM et al. Comparing PAP smear cytology, aided visual inspection, screening colposcopy, cervicography and HPV testing as optional screening tools in Latin America. Study design and baseline data of the LAMS study. Anticancer Res 2005 25 : 3469 80.
18. Solomon D Davey D Kurman R et al. The 2001 Bethesda System. Terminology for reporting results of cervical cytology. JAMA 2002 287 : 2114 9.
19. Lörincz AT Castle PE Sherman ME et al. Viral load of human papillomavirus and risk of CIN 3 or cervical cancer. Lancet 2002 360 : 288 9.
20. R Development Core Team. R: A language and environment for statistical computing. ISBN 3-900051-00-3. Vienna, Austria : R Foundation for Statistical Computing, 2004. Available at : http://www.R-project.org.
21. Cox JT Lorincz AT Schiffman MH et al. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995 172 : 946 54.
22. Clavel C Masure M Bory JP et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer 2001 84 : 1616 23.
23. Bulkmans NW Rozendaal L Snidjers PJ et al. POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer 2004 110 : 94 101.
24. Manos MM Kinney WK Hurley LB et al. Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA 1999 281 : 1605 10.
25. Denny L Kuhn L Pollack A et al. Direct visual inspection for cervical cancer screening: an analysis of factors influencing test performance. Cancer 2002 94 : 1699 707.
26. Sankaranarayanan R Nene BM Dinshaw K et al. Early detection of cervical cancer with visual inspection methods: a summary of completed and on-going studies in India. Salud Publica Mex 2003 45 ( Suppl. 3 S399 407.
27. dos Santos Silva I. Cancer epidemiology: principles and methods. Lyon, France : IARC, 1999 : 355 80.